This is a routine, pre-planned sale by the Chairman following a consistent monthly pattern. No material read-through for the stock. Monitor for any acceleration in selling frequency or volume in future Form 4/144 filings, which would be a more significant signal.
Price Chart
Executive Summary
Bruce C. Cozadd, Chairman and former CEO of Jazz Pharmaceuticals, filed a Form 144 notice of intent to sell 6,000 shares of common stock, with an approximate market value of $1.38 million based on the filing date price of ~$230.03. This is a routine, small disposition relative to his likely total holdings and the company's ~$14B market cap, and follows a pattern of periodic sales every 1-2 months (similar 6,000-share sales in July, August, and September 2026). The filing is neutral — it signals no material change in insider sentiment or company outlook.
Key Facts
- Insider: Bruce C. Cozadd (Chairman, former CEO)
- Shares to be sold: 6,000 shares of common stock
- Approximate market value: ~$1.38 million (based on $230.03/share on filing date)
- Broker: Merrill Lynch
- Sale intended on or after: October 1, 2026
- Shares acquired via stock options exercised on 3/1/2018 and 3/5/2025
- Prior sales: 6,000 shares each on 7/1/2026, 8/3/2026, and 9/1/2026 — consistent pattern of periodic small dispositions
Financial Impact
~$1.38 million sale, representing a small fraction of the insider's likely total holdings and <0.01% of Jazz's ~$14B market cap
Risk Factors
- No material risk — this is a routine insider sale consistent with prior pattern
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-064280 |
| Document: 0001628280-26-064280-index.html | 0001628280-26-064280 |
| Document: 0001628280-26-064280.txt | 0001628280-26-064280 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Press Release | $213.76 $211.97 | ▼ −0.84% | ▼ −1.36% | $210.99 (−1.30%) |
Oct 9, 2026 17d ago | 8-K | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 8, 2026 17d ago | 144 | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 6, 2026 19d ago | 144 | $231.19 $222.45 | ▼ −3.78% | ▼ −3.36% | $210.99 (−8.74%) |
Oct 1, 2026 24d ago | 144 | $235.67 $236.04 | ▲ +0.16% | ▼ −0.52% | $210.99 (−10.47%) |
Sep 15, 2026 5w ago | 8-K | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 14, 2026 5w ago | Insider Cluster | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 10, 2026 6w ago | Insider Cluster | $245.80 $245.87 | ▲ +0.03% | ▲ +0.47% | $210.99 (−14.16%) |
Sep 2, 2026 7w ago | Insider Cluster | $247.57 $246.81 | ▲ +0.30% | ▼ −0.08% | $210.99 (+14.78%) |
Aug 31, 2026 7w ago | 144 | $243.71 $245.57 | ▲ +0.76% | ▲ +0.32% | $210.99 (−13.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers